PLATINUM ANALOG COMBINATION CHEMOTHERAPY - CISPLATIN AND CARBOPLATIN - A PHASE-I TRIAL WITH PHARMACOKINETIC ASSESSMENT OF THE EFFECT OF CISPLATIN ADMINISTRATION ON CARBOPLATIN EXCRETION

被引：69
|
作者：
TRUMP, DL [1 ]
GREM, JL [1 ]
TUTSCH, KD [1 ]
WILLSON, JKV [1 ]
SIMON, KJ [1 ]
ALBERTI, D [1 ]
STORER, B [1 ]
TORMEY, DC [1 ]
机构：
[1] WILLIAM S MIDDLETON MEM VET ADM HOSP,MADISON,WI 53705
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1987年 / 5卷 / 08期
关键词：
D O I：
10.1200/JCO.1987.5.8.1281
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1281 / 1289
页数：9
相关论文
共 50 条
  • [31] Phase II trial of combination chemotherapy with cisplatin, carboplatin and etoposide in stage IIIB and IV small-cell lung cancer
    Nakanishi, Y
    Kawarada, Y
    Hirose, N
    Ninomiya, K
    Miyazaki, M
    Miyazaki, N
    Kurita, Y
    Kanegae, H
    Ohgushi, O
    Ogata, K
    Yamazaki, H
    Inutsuka, S
    Hara, N
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 41 (06) : 453 - 456
  • [32] Phase I study of a carboplatin-cisplatin-etoposide combination chemotherapy in advanced non-small-cell lung cancer
    Nakano, H
    Tsuchiya, S
    Takei, Y
    Minato, K
    Watanabe, S
    Makimoto, T
    Naruse, I
    Nomoto, T
    Ishihara, S
    Takise, A
    Ezawa, K
    Fueki, N
    Hoshino, H
    Saito, R
    Mori, M
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1996, 19 (03): : 245 - 248
  • [33] PHASE-I TRIAL OF CARBOPLATIN AND INFUSIONAL CYCLOSPORINE IN ADVANCED MALIGNANCY
    MORGAN, RJ
    MARGOLIN, K
    RASCHKO, J
    AKMAN, S
    LEONG, L
    SOMLO, G
    SCANLON, K
    AHN, C
    CARROLL, M
    DOROSHOW, JH
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (09) : 2238 - 2246
  • [34] Superiority of high-dose platinum (cisplatin and carboplatin) compared to carboplatin alone in combination chemotherapy for small-cell lung carcinoma: A prospective randomised trial of 280 consecutive patients
    Hirsch, FR
    Osterlind, K
    Jeppesen, N
    Dombernowsky, P
    Ingeberg, S
    Sorensen, PG
    Kristensen, C
    Hansen, HH
    ANNALS OF ONCOLOGY, 2001, 12 (05) : 647 - 653
  • [35] IS ESOPHAGEAL CANCER CHEMOSENSITIVE - SIGNIFICANCE OF A COMBINATION OF 2 PLATINUM SALTS (CARBOPLATIN AND CISPLATIN) AND FLUOROURACIL
    CURE, H
    PEZET, D
    FLEURY, J
    SLIM, K
    CHOLLET, P
    PLAGNE, R
    CHIPPONI, J
    REVUE DE MEDECINE INTERNE, 1993, 14 (06): : 413 - 413
  • [36] Cisplatin plus pirarubicin chemotherapy and combination ifomide, etoposide, pirarubicin and carboplatin chemotherapy for hepatoblastoma.
    Hiyama, E.
    Kamimatsuse, A.
    Kamei, N.
    Watanabe, K.
    Hishiki, T.
    Tajiri, T.
    Ida, K.
    Yano, M.
    Kondo, S.
    Sasaki, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [37] Phase I/II study of intraperitoneal floxuridine and platinums (cisplatin and/or carboplatin)
    Muggia, FM
    Jeffers, S
    Muderspach, L
    Roman, L
    Rosales, R
    Groshen, S
    Safra, T
    Morrow, CP
    GYNECOLOGIC ONCOLOGY, 1997, 66 (02) : 290 - 294
  • [38] A PILOT PHASE-II TRIAL OF A COMBINATION OF CISPLATIN AND CARBOPLATIN IN NONSMALL CELL LUNG-CANCER
    OHNO, S
    KOBAYASHI, J
    SUGIYAMA, Y
    KITAMURA, S
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A749 - A749
  • [39] PHASE-I STUDY OF A CARBOPLATIN ETOPOSIDE COMBINATION IN ADVANCED THORACIC CANCER
    TUENI, E
    SCULIER, JP
    KLASTERSKY, J
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (06): : 963 - 967
  • [40] A PHASE-I TRIAL OF COMBINATION CHEMOTHERAPY EMPLOYING CARBOPLATIN, VINCA ALKALOIDS, WITH OR WITHOUT BLEOMYCIN IN PATIENTS WITH ADVANCED MALIGNANT-TUMORS
    BAJORIN, D
    KELSEN, DP
    CANCER INVESTIGATION, 1990, 8 (02) : 135 - 141
12345